Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NALMEFENE vs NALOXONE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NALMEFENE vs NALOXONE: Safety Overview

Metric NALMEFENE NALOXONE
Total FAERS Reports 197 2,859
Deaths Reported 77 779
Death Rate 39.1% 27.2%
Hospitalizations 118 1,033
Average Patient Age 44.2 yrs 43.8 yrs
% Female Patients 39.3% 44.6%
FDA Approval Date Apr 17, 1995 Approved Prior to Jan 1, 1982
Manufacturer Purdue Pharma L.P. Meitheal Pharmaceuticals Inc.
Route INTRAMUSCULAR INTRAMUSCULAR
Marketing Status Discontinued Discontinued